Inovin

India
Contract manufacturing of pharmaceutical products, including sterile and oral solid doses, in India.

About Inovin

Inovin is a Healthcare company based in India. Contract manufacturing of pharmaceutical products, including sterile and oral solid doses, in India. Its Indian entity Inovin Pharmaceuticals Private Limited reported revenue of β‚Ή2.38 Cr. Inovin offers products and services including Sterile Fill-Finish and Oral Solid Dose. Its focus areas include Pharmaceuticals, Drug Manufacturing, Oral Solid Doses and Contract Manufacturing.

Company details

Inovin is recognized as a contract manufacturing organization that develops collaborative relationships to produce quality pharmaceutical products. Services such as sterile fill-finish for injectable products and oral solid dose manufacturing are offered, along with integrated packaging and analytical support. The company is noted for its established facilities with decades of experience in large-scale commercial supply, adhering to standards like ISO 9001:2015. Contact options are provided for client engagement in Chandigarh, India, emphasizing flexibility and attentiveness.

  • Headquarters India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website inovin.in
  • Social Facebook
  • Legal Name Inovin Pharmaceuticals Pvt. Ltd
  • Date of Incorporation 25 May, 2018
  • Jurisdiction Manimajra, Chandigarh, India
Key Metrics
  • Annual Revenue
    ₹2.38 Cr

    FY 2025 · +14% YoY

  • Net Profit
    ₹4.3 Lakh

    FY 2025 · 2% margin

  • EBITDA
    ₹12.8 Lakh

    FY 2025 · 5% margin

Products & Services of Inovin

Inovin offers a comprehensive portfolio of products and services, including Sterile Fill-Finish and Oral Solid Dose.

Sterile Fill-Finish
Manufacturing Services

Sterile injectable products are manufactured by Inovin, including liquid and lyophilized fill-finish with terminal sterilization.

Oral Solid Dose
Manufacturing Services

Oral solid dose drug products are manufactured by Inovin at clinical and commercial scales, covering potent compounds and targeted release formulations.

Board of directors of Inovin Pharmaceuticals Private Limited (Inovin)

Inovin Pharmaceuticals Private Limited is the primary company behind Inovin. The board of Inovin Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Rishabh Garg, appointed in 2020. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rishabh Garg
DIN 08672173
Additional Director13 Jan 20206 yrs 10 moInovin Pharmaceuticals Private Limited
Manav Garg
DIN 09845603
Director02 Jan 20233 yrs 10 moInovin Pharmaceuticals Private Limited

Financials of Inovin

Figures of Inovin Pharmaceuticals Private Limited, the primary company behind Inovin, for FY 2025. Revenue was ₹2.38 Cr (+14% year on year). Net profit was ₹4.3 Lakh (2% margin). EBITDA was ₹12.8 Lakh (5% margin). Revenue has grown at a compounded annual rate of +44% over three years.

  • ₹2.38 CrRevenue · FY 2025 · +14% YoY
  • ₹4.3 LakhNet profit · 2% margin
  • ₹12.8 LakhEBITDA · 5% margin
  • ₹1 LakhPaid-up capital
  • +44%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Inovin Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Inovin

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Inovin

Inovin is headquartered in India.

The primary company behind Inovin, Inovin Pharmaceuticals Private Limited, reported revenue of β‚Ή2.38 Cr for FY 2025, up 14% year on year.

Inovin is recognized as a contract manufacturing organization that develops collaborative relationships to produce quality pharmaceutical products. Services such as sterile fill-finish for injectable products and oral solid dose manufacturing are offered, along with integrated packaging and analytical support. The company is noted for its established facilities with decades of experience in large-scale commercial supply, adhering to standards like ISO 9001:2015. Contact options are provided for client engagement in Chandigarh, India, emphasizing flexibility and attentiveness.

Inovin offers Sterile Fill-Finish and Oral Solid Dose.

Inovin operates through Inovin Pharmaceuticals Private Limited.

The legal entities of Inovin currently have 2 directors, including Manav Garg, Rishabh Garg.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available